Company Filing History:
Years Active: 2018
Title: The Innovations of Steven Dakin
Introduction
Steven Dakin is an accomplished inventor based in Auckland, New Zealand. He has made significant contributions to the field of vision science, particularly in understanding binocular vision impairment. His innovative approach has led to the development of a unique patent that addresses a critical aspect of visual perception.
Latest Patents
Dakin holds a patent titled "Quantification of inter-ocular suppression in binocular vision impairment." This patent encompasses systems, apparatus, and methods designed to quantify inter-ocular suppression in individuals experiencing binocular vision impairment. The technology involves a stimulus presentation device and a controller that presents different stimuli to each eye of a patient. The stimuli can include letters, numbers, or shapes arranged in rows and columns, with each eye receiving a stimulus corresponding to the other eye. The combined contrast of these stimuli is set to a predetermined value, which can be adjusted based on the patient's feedback and an algorithm executed by the controller. This innovative method allows for the quantification of suppression in relation to visual field location.
Career Highlights
Throughout his career, Steven Dakin has focused on advancing the understanding of visual perception and its impairments. His work has been instrumental in developing new methodologies for assessing and treating binocular vision issues. Dakin's dedication to research and innovation has positioned him as a key figure in the field.
Collaborations
Steven has collaborated with notable colleagues, including Peter Bex and MiYoung Kwon. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in vision science.
Conclusion
Steven Dakin's contributions to the field of vision science through his patent and collaborative efforts highlight his commitment to improving the understanding and treatment of binocular vision impairment. His work continues to inspire advancements in this critical area of research.